Pan J, Deng B, Liu S, et al. Efficacy and safety of CD22-directed CAR-T cell therapy in 15 pediatric refractory or relapsed B acute lymphoblastic leukemia patients. EHA 2018, abstract 832.
FDA geeft dasatinib review-prioriteit bij behandeling pediatrische CML
okt 2017 | Leukemie